Adjuvant docetaxel plus cisplatin in stage I/II non-small cell lung cancer (NSCLC): Preliminary results of a randomized phase II pilot trial of the Central European Cooperative Oncology Group (CECOG) (original) (raw)

Journal of Clinical Oncology, 2004

Abstract

7297 Background: Adjuvant chemotherapy treatment for early stage NSCLC patients is not yet standard practice. The aim of the present trial is to compare the activity, safety, and quality of life ef...

Sandra Tomek hasn't uploaded this paper.

Let Sandra know you want this paper to be uploaded.

Ask for this paper to be uploaded.